Flashback to March 2018…there was a blue beam shining into the sky in Newbury Park for a number of nights and I was determined to find the source. I found it! The beam was coming from our local biotech powerhouse Amgen. The bright blue nightly beam was part of Amgen’s month-long “Spotlight Myeloma” initiative as part of Multiple Myeloma Awareness Month.
March 2019 once again is Multiple Myeloma Awareness Month, a time to recognize the patients, caregivers and healthcare providers who work courageously to improve the daily lives of patients living with this incurable blood cancer. Once again, Amgen will be shining a nightly beam into the sky; this year’s burgundy beam will shine March 17-29.
Although it’s the second most common blood cancer, multiple myeloma is rare. It’s estimated that only 32,000 people in the U.S. will be diagnosed with the disease this year.